The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes

doi:10.2337/dc06-1441

The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

Andrew D. Paterson, MD1,
Brandy N. Rutledge, PHD2,
Patricia A. Cleary, MS2,
John M. Lachin, SCD2,
Richard S. Crow, MD3 and
for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group*

¹Program in Genetics and Genomic Biology, The Hospital for Sick Children, and Departments of Public Health Sciences, Psychiatry and Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
²Biostatistics Center, The George Washington University, Rockville, Maryland
³Minnesota ECG Coding Center, Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota

Address correspondence and reprint requests to Dr. Andrew Paterson, Program in Genetics and Genomic Biology, The Hospital for Sick Children, TMDT Building East Tower, Room 15-707, 101 College St., Toronto, ON M5G 1L7, Canada. E-mail: andrew.paterson{at}utoronto.ca

Abstract

OBJECTIVE—Cardiovascular disease is a major cause of morbidity and mortality in individuals with type 1 diabetes. Resting heart rate (RHR) is a risk factor for cardiovascular disease in the general population, and case-control studies have reported a higher RHR in individuals with type 1 diabetes. In individuals with type 1 diabetes, there is a positive correlation between A1C and RHR; however, no prospective studies have examined whether a causal relationship exists between A1C and RHR. We hypothesized that intensive diabetes treatment aimed to achieve normal A1C levels has an effect on RHR in individuals with type 1 diabetes.

RESEARCH DESIGN AND METHODS—A total of 1,441 individuals with type 1 diabetes who participated in the Diabetes Control and Complications Trial (DCCT) had their RHR measured biennially by an electrocardiogram during the DCCT and annually for 10 years during the Epidemiology of Diabetes Interventions and Complications (EDIC) follow-up study.

RESULTS—During the DCCT, intensive treatment was associated with lower mean RHR than conventional treatment, both in adolescents (69.0 vs. 72.0 bpm [95% CI 62.8–75.7 and 65.7–78.9, respectively], P = 0.013) and adults (66.8 vs. 68.2 [65.3–68.4 and 66.6–69.8, respectively], P = 0.0014). During follow-up in the EDIC, the difference in RHR between the treatment groups persisted for at least 10 years (P < 0.0001).

CONCLUSIONS—Compared with conventional therapy, intensive diabetes management is associated with lower RHR in type 1 diabetes. The lower RHR with intensive therapy may explain, in part, its effect in reducing cardiovascular disease, recently demonstrated in type 1 diabetes.

Footnotes

↵* A complete list of investigators and members of the Research Group appears in ref. 40.
Published ahead of print at http://care.diabetesjournals.org on 27 April 2007. DOI: 10.2337/dc06-1441.

Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/dc06-1441.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- Accepted April 23, 2007.
- Received August 11, 2006.
DIABETES CARE